Q&A with Jay Crone and Jon Wolkin, directors, Telus Ventures

Baidu’s corporate venturing arm has re-invested in the immunotherapy developer to help commercialise its pipeline.

Notre Dame’s Pit Road Fund has re-invested in the enterprise blockchain deployment platform and was joined by Stanford Law School Venture Fund.

The Citi and Alphabet-backed real estate platform hauled in $100m in series D equity and $263m in debt.

Versanis Bio secured $70 to commercialise a treatment licensed from Novartis, while Salesforce, Intel, Orange, Nike and Alphabet all celebrated exits.

The GV-backed candidate checking platform developer is fuelling its growth with fresh capital from FMR and stalwart investor T Rowe Price.

Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms and Dentsu Ventures are all shareholders in the diagnostic testing technology developer.

The blood disease specialist secured a boost from Alexandria Real Estate Equities, Novo and Access Biotechnology to move two assets into phase 2 trials.

The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Osage University Partners.

The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Capital One and CrowdStrike.